Advocating for cervical cancer prevention

Cervical cancer is a significant health problem among women in developing countries. Contributing to the cervical cancer health burden in many countries is a lack of understanding and political will to address the problem. Broad-based advocacy efforts that draw on research and program findings from...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of gynecology and obstetrics 2005-05, Vol.89 (S2), p.S46-S54
Hauptverfasser: Sherris, J., Agurto, I., Arrossi, S., Dzuba, I., Gaffikin, L., Herdman, C., Limpaphayom, K., Luciani, S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page S54
container_issue S2
container_start_page S46
container_title International journal of gynecology and obstetrics
container_volume 89
creator Sherris, J.
Agurto, I.
Arrossi, S.
Dzuba, I.
Gaffikin, L.
Herdman, C.
Limpaphayom, K.
Luciani, S.
description Cervical cancer is a significant health problem among women in developing countries. Contributing to the cervical cancer health burden in many countries is a lack of understanding and political will to address the problem. Broad-based advocacy efforts that draw on research and program findings from developing-country settings are key to gaining program and policy support, as are cost-effectiveness analyses based on these findings. The Alliance for Cervical Cancer Prevention (ACCP) has undertaken advocacy efforts at the international, regional, national, and local levels to raise awareness and understanding of the problem (and workable solutions), galvanize funders and governments to take action, and engage local stakeholders in ensuring program success. ACCP experience demonstrates the role that evidence-based advocacy efforts play in the ultimate success of cervical cancer prevention programs, particularly when new screening and treatment approaches—and, ultimately, radically new approaches such as a human papillomavirus vaccine—are available.
doi_str_mv 10.1016/j.ijgo.2005.01.010
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67727408</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0020729205000494</els_id><sourcerecordid>67727408</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5126-a7e89989d8ac38279d98b89d1a63952bdd3fde013ce9a971562861135deb2a233</originalsourceid><addsrcrecordid>eNqNkEFLAzEQhYMotlb_gAfpSfCwdSbpbhLwUopWpeBBPYc0mUrKdrcmbcV_b0oL3kR4MDPw3mP4GLtEGCBgdbsYhMVHO-AA5QAwC45YF5XUhRhKfcy6ABwKyTXvsLOUFgCAEvGUdbBUXPBKdtnNyG9bZ9eh-ejP29h3FLfB2brvbJP3_irSlpp1aJtzdjK3daKLw-yx94f7t_FjMX2ZPI1H08KVyKvCSlJaK-2VdUJxqb1Ws3yirYQu-cx7MfcEKBxpqyWWFVcVoig9zbjlQvTY9b53FdvPDaW1WYbkqK5tQ-0mmUpKLoegspHvjS62KUWam1UMSxu_DYLZATILswNkdoAMYBbk0NWhfTNbkv-NHIhkg9wbvkJN3_-oNE_Pk5fXYZWTd_skZTrbQNEkFyhT9CGSWxvfhr8--wEziYa3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67727408</pqid></control><display><type>article</type><title>Advocating for cervical cancer prevention</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Sherris, J. ; Agurto, I. ; Arrossi, S. ; Dzuba, I. ; Gaffikin, L. ; Herdman, C. ; Limpaphayom, K. ; Luciani, S.</creator><creatorcontrib>Sherris, J. ; Agurto, I. ; Arrossi, S. ; Dzuba, I. ; Gaffikin, L. ; Herdman, C. ; Limpaphayom, K. ; Luciani, S.</creatorcontrib><description>Cervical cancer is a significant health problem among women in developing countries. Contributing to the cervical cancer health burden in many countries is a lack of understanding and political will to address the problem. Broad-based advocacy efforts that draw on research and program findings from developing-country settings are key to gaining program and policy support, as are cost-effectiveness analyses based on these findings. The Alliance for Cervical Cancer Prevention (ACCP) has undertaken advocacy efforts at the international, regional, national, and local levels to raise awareness and understanding of the problem (and workable solutions), galvanize funders and governments to take action, and engage local stakeholders in ensuring program success. ACCP experience demonstrates the role that evidence-based advocacy efforts play in the ultimate success of cervical cancer prevention programs, particularly when new screening and treatment approaches—and, ultimately, radically new approaches such as a human papillomavirus vaccine—are available.</description><identifier>ISSN: 0020-7292</identifier><identifier>EISSN: 1879-3479</identifier><identifier>DOI: 10.1016/j.ijgo.2005.01.010</identifier><identifier>PMID: 15823267</identifier><language>eng</language><publisher>United States: Elsevier Ireland Ltd</publisher><subject>Advocacy ; Cervical cancer ; Cervical Intraepithelial Neoplasia - prevention &amp; control ; Cost-Benefit Analysis ; Developing Countries ; Female ; Global Health ; Humans ; Patient Advocacy - economics ; Policy ; Prevention ; Program Development ; Stakeholders ; Uterine Cervical Neoplasms - prevention &amp; control ; Women's Health Services - economics</subject><ispartof>International journal of gynecology and obstetrics, 2005-05, Vol.89 (S2), p.S46-S54</ispartof><rights>2005 International Federation of Gynecology and Obstetrics</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5126-a7e89989d8ac38279d98b89d1a63952bdd3fde013ce9a971562861135deb2a233</citedby><cites>FETCH-LOGICAL-c5126-a7e89989d8ac38279d98b89d1a63952bdd3fde013ce9a971562861135deb2a233</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1016%2Fj.ijgo.2005.01.010$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1016%2Fj.ijgo.2005.01.010$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,778,782,1414,27911,27912,45561,45562</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15823267$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sherris, J.</creatorcontrib><creatorcontrib>Agurto, I.</creatorcontrib><creatorcontrib>Arrossi, S.</creatorcontrib><creatorcontrib>Dzuba, I.</creatorcontrib><creatorcontrib>Gaffikin, L.</creatorcontrib><creatorcontrib>Herdman, C.</creatorcontrib><creatorcontrib>Limpaphayom, K.</creatorcontrib><creatorcontrib>Luciani, S.</creatorcontrib><title>Advocating for cervical cancer prevention</title><title>International journal of gynecology and obstetrics</title><addtitle>Int J Gynaecol Obstet</addtitle><description>Cervical cancer is a significant health problem among women in developing countries. Contributing to the cervical cancer health burden in many countries is a lack of understanding and political will to address the problem. Broad-based advocacy efforts that draw on research and program findings from developing-country settings are key to gaining program and policy support, as are cost-effectiveness analyses based on these findings. The Alliance for Cervical Cancer Prevention (ACCP) has undertaken advocacy efforts at the international, regional, national, and local levels to raise awareness and understanding of the problem (and workable solutions), galvanize funders and governments to take action, and engage local stakeholders in ensuring program success. ACCP experience demonstrates the role that evidence-based advocacy efforts play in the ultimate success of cervical cancer prevention programs, particularly when new screening and treatment approaches—and, ultimately, radically new approaches such as a human papillomavirus vaccine—are available.</description><subject>Advocacy</subject><subject>Cervical cancer</subject><subject>Cervical Intraepithelial Neoplasia - prevention &amp; control</subject><subject>Cost-Benefit Analysis</subject><subject>Developing Countries</subject><subject>Female</subject><subject>Global Health</subject><subject>Humans</subject><subject>Patient Advocacy - economics</subject><subject>Policy</subject><subject>Prevention</subject><subject>Program Development</subject><subject>Stakeholders</subject><subject>Uterine Cervical Neoplasms - prevention &amp; control</subject><subject>Women's Health Services - economics</subject><issn>0020-7292</issn><issn>1879-3479</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkEFLAzEQhYMotlb_gAfpSfCwdSbpbhLwUopWpeBBPYc0mUrKdrcmbcV_b0oL3kR4MDPw3mP4GLtEGCBgdbsYhMVHO-AA5QAwC45YF5XUhRhKfcy6ABwKyTXvsLOUFgCAEvGUdbBUXPBKdtnNyG9bZ9eh-ejP29h3FLfB2brvbJP3_irSlpp1aJtzdjK3daKLw-yx94f7t_FjMX2ZPI1H08KVyKvCSlJaK-2VdUJxqb1Ws3yirYQu-cx7MfcEKBxpqyWWFVcVoig9zbjlQvTY9b53FdvPDaW1WYbkqK5tQ-0mmUpKLoegspHvjS62KUWam1UMSxu_DYLZATILswNkdoAMYBbk0NWhfTNbkv-NHIhkg9wbvkJN3_-oNE_Pk5fXYZWTd_skZTrbQNEkFyhT9CGSWxvfhr8--wEziYa3</recordid><startdate>200505</startdate><enddate>200505</enddate><creator>Sherris, J.</creator><creator>Agurto, I.</creator><creator>Arrossi, S.</creator><creator>Dzuba, I.</creator><creator>Gaffikin, L.</creator><creator>Herdman, C.</creator><creator>Limpaphayom, K.</creator><creator>Luciani, S.</creator><general>Elsevier Ireland Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200505</creationdate><title>Advocating for cervical cancer prevention</title><author>Sherris, J. ; Agurto, I. ; Arrossi, S. ; Dzuba, I. ; Gaffikin, L. ; Herdman, C. ; Limpaphayom, K. ; Luciani, S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5126-a7e89989d8ac38279d98b89d1a63952bdd3fde013ce9a971562861135deb2a233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Advocacy</topic><topic>Cervical cancer</topic><topic>Cervical Intraepithelial Neoplasia - prevention &amp; control</topic><topic>Cost-Benefit Analysis</topic><topic>Developing Countries</topic><topic>Female</topic><topic>Global Health</topic><topic>Humans</topic><topic>Patient Advocacy - economics</topic><topic>Policy</topic><topic>Prevention</topic><topic>Program Development</topic><topic>Stakeholders</topic><topic>Uterine Cervical Neoplasms - prevention &amp; control</topic><topic>Women's Health Services - economics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sherris, J.</creatorcontrib><creatorcontrib>Agurto, I.</creatorcontrib><creatorcontrib>Arrossi, S.</creatorcontrib><creatorcontrib>Dzuba, I.</creatorcontrib><creatorcontrib>Gaffikin, L.</creatorcontrib><creatorcontrib>Herdman, C.</creatorcontrib><creatorcontrib>Limpaphayom, K.</creatorcontrib><creatorcontrib>Luciani, S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of gynecology and obstetrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sherris, J.</au><au>Agurto, I.</au><au>Arrossi, S.</au><au>Dzuba, I.</au><au>Gaffikin, L.</au><au>Herdman, C.</au><au>Limpaphayom, K.</au><au>Luciani, S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Advocating for cervical cancer prevention</atitle><jtitle>International journal of gynecology and obstetrics</jtitle><addtitle>Int J Gynaecol Obstet</addtitle><date>2005-05</date><risdate>2005</risdate><volume>89</volume><issue>S2</issue><spage>S46</spage><epage>S54</epage><pages>S46-S54</pages><issn>0020-7292</issn><eissn>1879-3479</eissn><abstract>Cervical cancer is a significant health problem among women in developing countries. Contributing to the cervical cancer health burden in many countries is a lack of understanding and political will to address the problem. Broad-based advocacy efforts that draw on research and program findings from developing-country settings are key to gaining program and policy support, as are cost-effectiveness analyses based on these findings. The Alliance for Cervical Cancer Prevention (ACCP) has undertaken advocacy efforts at the international, regional, national, and local levels to raise awareness and understanding of the problem (and workable solutions), galvanize funders and governments to take action, and engage local stakeholders in ensuring program success. ACCP experience demonstrates the role that evidence-based advocacy efforts play in the ultimate success of cervical cancer prevention programs, particularly when new screening and treatment approaches—and, ultimately, radically new approaches such as a human papillomavirus vaccine—are available.</abstract><cop>United States</cop><pub>Elsevier Ireland Ltd</pub><pmid>15823267</pmid><doi>10.1016/j.ijgo.2005.01.010</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0020-7292
ispartof International journal of gynecology and obstetrics, 2005-05, Vol.89 (S2), p.S46-S54
issn 0020-7292
1879-3479
language eng
recordid cdi_proquest_miscellaneous_67727408
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Advocacy
Cervical cancer
Cervical Intraepithelial Neoplasia - prevention & control
Cost-Benefit Analysis
Developing Countries
Female
Global Health
Humans
Patient Advocacy - economics
Policy
Prevention
Program Development
Stakeholders
Uterine Cervical Neoplasms - prevention & control
Women's Health Services - economics
title Advocating for cervical cancer prevention
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T21%3A27%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Advocating%20for%20cervical%20cancer%20prevention&rft.jtitle=International%20journal%20of%20gynecology%20and%20obstetrics&rft.au=Sherris,%20J.&rft.date=2005-05&rft.volume=89&rft.issue=S2&rft.spage=S46&rft.epage=S54&rft.pages=S46-S54&rft.issn=0020-7292&rft.eissn=1879-3479&rft_id=info:doi/10.1016/j.ijgo.2005.01.010&rft_dat=%3Cproquest_cross%3E67727408%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67727408&rft_id=info:pmid/15823267&rft_els_id=S0020729205000494&rfr_iscdi=true